Callan Family Office, LLC
Family OfficePosition in PBH — Prestige Consumer Healthcare Inc.
CIK 1938970
RADNOR, PA
Position in PBH
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$513,633
-$51,944 QoQ
Shares Held
8,666
+22.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Jun 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in PBH Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Callan Family Office, LLC holds $21,578,279 across 11 Drug Manufacturers - Specialty & Generic names. PBH ranks #7 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | HLN |
Haleon plc
|
734,570 | $7,353,045 | |
| 2 | ELAN |
Elanco Animal Health Inc
|
164,316 | $3,932,081 | |
| 3 | TAK |
Takeda Pharmaceutical Co Ltd
|
162,957 | $3,017,963 | |
| 4 | ZTS |
Zoetis Inc.
|
21,685 | $2,563,383 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
|
63,254 | $1,905,210 | |
| 6 | UTHR |
UNITED THERAPEUTICS Corp
|
2,083 | $1,235,177 | |
| 7 | PBH |
Prestige Consumer Healthcare Inc.
This page
|
8,666 | $513,633 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
18,020 | $374,095 |
All Filings in PBH
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $513,633 | 8,666 | Shares | Sole | 2026-05-13 | |
| 2025-06-30 | $565,577 | 7,083 | Shares | Sole | 2025-07-24 | |
| No filing history on record for this holder in this stock. | ||||||